Published in BJU Int on October 23, 2014
Robotic surgery in gynecology. J Minim Access Surg (2015) 0.90
Is the robotic approach feasible for repair of iatrogenic injuries of the lower ureter? World J Urol (2016) 0.78
Re: Robotic Management of Genitourinary Injuries from Obstetric and Gynaecological Operations: A Multi-Institutional Report of Outcomes. J Urol (2015) 0.75
A Case of Type 2 Youssef's Syndrome following Caesarean Section for Placenta Previa Totalis. Case Rep Obstet Gynecol (2016) 0.75
The robot to the rescue! Editorial on robotic management of genitourinary injuries from obstetric and gynaecological operations: a multi-institutional report of outcomes. BJU Int (2015) 0.75
Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer (2011) 3.54
Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time. Cancer (2012) 2.98
Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. J Urol (2013) 2.76
Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques. J Urol (2005) 2.49
Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol (2010) 2.35
Vattikuti Institute prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases. Urol Clin North Am (2004) 2.15
Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis. J Endourol (2015) 2.05
Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol (2011) 1.76
Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J Biol Chem (2001) 1.69
Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J Clin Invest (2003) 1.67
Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol (2010) 1.67
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J Biol Chem (2002) 1.62
Anastomosis during robot-assisted radical prostatectomy: randomized controlled trial comparing barbed and standard monofilament suture. Urology (2011) 1.61
Robotic nephrectomy for the treatment of benign and malignant disease. BJU Int (2008) 1.60
Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients. BJU Int (2006) 1.59
VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha. EMBO Rep (2005) 1.57
Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem Biophys Res Commun (2002) 1.56
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol (2009) 1.53
Management of rectal injury during robotic radical prostatectomy. Urology (2011) 1.52
Maximizing console surgeon independence during robot-assisted renal surgery by using the Fourth Arm and TilePro. J Endourol (2009) 1.49
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer (2004) 1.45
Complications associated with extraperitoneal robot-assisted radical prostatectomy using the standardized Martin classification. Urology (2013) 1.44
Robotic partial nephrectomy in the setting of prior abdominal surgery. BJU Int (2010) 1.44
Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis. Can J Urol (2015) 1.42
Comparison of two-dimensional and three-dimensional suturing: is there a difference in a robotic surgery setting? J Endourol (2005) 1.41
Posterior support for urethrovesical anastomosis in robotic radical prostatectomy: single surgeon analysis. Can J Urol (2009) 1.41
Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens. Mod Pathol (2011) 1.41
Risk factors associated with 30 day hospital readmission following partial nephrectomy. Can J Urol (2015) 1.40
Examining the relationship between operative time and hospitalization time in minimally invasive and open urologic procedures. J Endourol (2014) 1.39
Robotic-assisted aortic surgery with and without minilaparotomy for complicated occlusive disease and aneurysm. J Vasc Surg (2011) 1.39
High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol (2003) 1.35
Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for renal cortical tumors. J Urol (2011) 1.35
Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark (2008) 1.34
Quantitative characterization of viscoelastic properties of human prostate correlated with histology. Ultrasound Med Biol (2008) 1.30
The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. EMBO J (2003) 1.24
Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol (2004) 1.23
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clin Genitourin Cancer (2012) 1.22
Robotic partial nephrectomy for renal tumors larger than 4 cm. Eur Urol (2009) 1.20
Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem (2002) 1.20
Major complications in 213 laparoscopic nephrectomy cases: the Indianapolis experience. J Urol (2002) 1.18
Robot-assisted and laparoscopic partial nephrectomy with near infrared fluorescence imaging. J Endourol (2012) 1.15
Congruence of imaging estimators and mechanical measurements of viscoelastic properties of soft tissues. Ultrasound Med Biol (2007) 1.12
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. EMBO J (2003) 1.12
Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J Lipid Res (2010) 1.12
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway. J Biol Chem (2005) 1.11
Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumors. Urology (2012) 1.08
Is it worth revisiting laparoscopic three-dimensional visualization? A validated assessment. Urology (2007) 1.05
COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem (2002) 1.05
Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int (2011) 1.05
Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology (2002) 1.04
Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system. BJU Int (2012) 1.03
Novel prostate-specific promoter derived from PSA and PSMA enhancers. Mol Ther (2002) 1.03
Robotic and laparoscopic surgery: cost and training. Surg Oncol (2009) 1.03
The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol (2005) 1.02
Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer. Hum Gene Ther (2003) 1.00
Targeted lipidomics: discovery of new fatty acyl amides. AAPS J (2006) 0.99
CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology (2002) 0.99
New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology (2003) 0.98
Midline crossing and Slit responsiveness of commissural axons require USP33. Nat Neurosci (2009) 0.98
A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling. Biochem Biophys Res Commun (2004) 0.97
Robotic radical prostatectomy with preservation of the prostatic fascia: a feasibility study. Urology (2005) 0.97
Impact of ureteral stent diameter on symptoms and tolerability. J Endourol (2003) 0.96
Effect of metabolic syndrome on pathologic features of prostate cancer. Urol Oncol (2012) 0.96
Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer. Cancer Res (2005) 0.96
Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int (2008) 0.95
Race/ethnicity-based concerns over understanding cancer diagnosis and treatment plan. J Natl Med Assoc (2010) 0.95
A novel method of urethrovesical anastomosis during robot-assisted radical prostatectomy using a unidirectional barbed wound closure device: feasibility study and early outcomes in 51 patients. J Endourol (2010) 0.94
Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies. BJU Int (2012) 0.94
Ureteritis cystica: a radiologic pathologic correlation. J Clin Imaging Sci (2011) 0.94
Barbed suture for renorrhaphy during robot-assisted partial nephrectomy. J Endourol (2011) 0.94
[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem (2004) 0.94
Manual specimen retrieval without a pneumoperitoneum preserving device for laparoscopic live donor nephrectomy. J Urol (2002) 0.94
One versus two proficient laparoscopic surgeons for laparoscopic live donor nephrectomy. Urology (2002) 0.93
Robot-assisted partial nephrectomy in obese patients. J Endourol (2011) 0.93
Impact of prostate size in robot-assisted radical prostatectomy. J Endourol (2007) 0.93
Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Cancer Gene Ther (2004) 0.92
R.E.N.A.L. Nephrometry scoring: how well correlated are urologist, radiologist, and collaborator scores? J Endourol (2014) 0.92
Robot-assisted extraperitoneal radical prostatectomy in a patient with a pelvic kidney. Urology (2006) 0.91
The impact of previous inguinal or abdominal surgery on outcomes after robotic radical prostatectomy. Urology (2009) 0.91
Transperitoneal laparoscopic renal surgery using blunt 12-mm trocar without fascial closure. J Endourol (2002) 0.91
Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.90
Multispectral Photoacoustic Imaging of Prostate Cancer: Preliminary Ex-vivo Results. J Clin Imaging Sci (2013) 0.90
Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol (2003) 0.89
Robot-assisted radical prostatectomy in obese patients. Can J Urol (2006) 0.89
Reducing robotic prostatectomy costs by minimizing instrumentation. J Endourol (2014) 0.88
Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis. J Gene Med (2006) 0.88
Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter. Mol Cancer Ther (2005) 0.88
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Anticancer Res (2004) 0.87
Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells. J Exp Clin Cancer Res (2013) 0.87
Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy. Clin Cancer Res (2008) 0.87
The technique of single stage pure robotic nephroureterectomy. J Endourol (2012) 0.87
Bladder dysfunction in patients with diabetes. Curr Urol Rep (2011) 0.86
Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder. Adv Urol (2009) 0.86
Porous graphitic carbon nitride synthesized via direct polymerization of urea for efficient sunlight-driven photocatalytic hydrogen production. Nanoscale (2012) 0.86